These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 4930603

  • 21. [Ultrastructural lesions of the liver in subacute alcoholic hepatitis and cirrhogenous alcoholic hepatitis].
    Albot G, Parturier-Albot M.
    Sem Hop; 1966 Jun 14; 42(29):1757-71. PubMed ID: 4287603
    [No Abstract] [Full Text] [Related]

  • 22. Glucocorticoids in liver diseases.
    Quaade F.
    Acta Med Scand Suppl; 1969 Jun 14; 500():49-54. PubMed ID: 5270161
    [No Abstract] [Full Text] [Related]

  • 23. [Clinical problems of alcoholic cirrhosis. I. Biological and clinical characteristics of the alcoholic cirrhosis of the liver].
    Knezević S, Falisevac V, Kallai L, Hadzić N, Pichler E, Spicer F.
    Acta Med Iugosl; 1974 Jun 14; 28(4):339-53. PubMed ID: 4422443
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial.
    Trinchet JC, Beaugrand M, Callard P, Hartmann DJ, Gotheil C, Nusgens BV, Lapiere CM, Ferrier JP.
    Gastroenterol Clin Biol; 1989 Jun 14; 13(6-7):551-5. PubMed ID: 2753302
    [Abstract] [Full Text] [Related]

  • 25. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P, Astellas Corticosteroid Withdrawal Study Group.
    Ann Surg; 2008 Oct 14; 248(4):564-77. PubMed ID: 18936569
    [Abstract] [Full Text] [Related]

  • 26. [Mesenchyma-suppressing therapy of chronic aggressive hepatitis].
    Gros H, Zwirner K, Herzog W.
    Med Klin; 1972 Oct 06; 67(40):1277-82. PubMed ID: 4638147
    [No Abstract] [Full Text] [Related]

  • 27. A prospective trial of steroid therapy in severe viral hepatitis. The prognostic significance of bridging necrosis.
    Ware AJ, Cuthbert JA, Shorey J, Gurian LE, Eigenbrodt EH, Combes B.
    Gastroenterology; 1981 Feb 06; 80(2):219-24. PubMed ID: 7004995
    [Abstract] [Full Text] [Related]

  • 28. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E, Papatheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):80-9. PubMed ID: 17919273
    [Abstract] [Full Text] [Related]

  • 29. [Clinical, biologic and histologic study of 10 patients affected with alcoholic hepatitis subjected to a thermal cure at Vichy].
    Bonnet GF.
    Rev Int Hepatol; 1968 Jan 01; 18(8):947-66. PubMed ID: 4891301
    [No Abstract] [Full Text] [Related]

  • 30. [Immunodepressive therapy of chronic aggressive hepatitis].
    Gros H, Zwirner K.
    Munch Med Wochenschr; 1969 Nov 28; 111(48):2481-5. PubMed ID: 5396025
    [No Abstract] [Full Text] [Related]

  • 31. Editorial: Biopsy in alcoholic liver disease.
    Lough J.
    Can Med Assoc J; 1974 May 18; 110(10):1121 passim. PubMed ID: 4829830
    [No Abstract] [Full Text] [Related]

  • 32. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.
    Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, Bense S, Theil D, Jahn K, Brandt T.
    N Engl J Med; 2004 Jul 22; 351(4):354-61. PubMed ID: 15269315
    [Abstract] [Full Text] [Related]

  • 33. [Characteristics of alcoholic liver diseases in Japan, with special reference to the modification brought about by viral hepatitis].
    Haga M, Sato G, Toyokawa H, Yamamoto J.
    Nihon Rinsho; 1976 Nov 10; 34(11):3153-8. PubMed ID: 1034761
    [No Abstract] [Full Text] [Related]

  • 34. Exchange transfusions for intractable hepatic coma. Successful treatment of a patient with alcoholic hepatitis.
    Szwed JJ, Grisell TW, Mendenhall CL.
    Arch Intern Med; 1969 Apr 10; 123(4):441-4. PubMed ID: 5778124
    [No Abstract] [Full Text] [Related]

  • 35. Alcoholic liver disease in alcoholic chronic pancreatitis: a prospective study.
    Gullo L, Casadei R, Campione O, Grigioni W, Marrano D.
    Ital J Gastroenterol; 1995 Mar 10; 27(2):69-72. PubMed ID: 7579594
    [Abstract] [Full Text] [Related]

  • 36. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG, Floch MH, Conn HO.
    N Engl J Med; 1969 Aug 21; 281(8):408-12. PubMed ID: 4894464
    [No Abstract] [Full Text] [Related]

  • 37. Hypogonadism in alcoholic liver disease: evidence for a double defect.
    Van Thiel DH, Lester R, Sherins RJ.
    Gastroenterology; 1974 Dec 21; 67(6):1188-99. PubMed ID: 4430432
    [No Abstract] [Full Text] [Related]

  • 38. Analysis of a certain type of 2 x 3 tables, exemplified by biopsy findings in a controlled clinical trial.
    Scheiber V, Wohlzogen FX.
    Int J Clin Pharmacol Biopharm; 1978 Nov 21; 16(11):533-5. PubMed ID: 365798
    [Abstract] [Full Text] [Related]

  • 39. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 21; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 40. Treatment of chronic active hepatitis. An analysis of three controlled trials.
    Wright EC, Seeff LB, Berk PD, Jones A, Plotz PH.
    Gastroenterology; 1977 Dec 21; 73(6):1422-30. PubMed ID: 334625
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.